Nail pigmentation due to hydroxycarbamide
| Autor: | Pamela Poblete-Gutiérrez, Jorge Frank, Roeland P. M. Ceulen |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Male
medicine.medical_specialty Side effect business.industry Chronic myeloproliferative disease Dermatology Middle Aged Hyperpigmentation Hydroxycarbamide Nail Diseases medicine.anatomical_structure Melanonychia Subungual malignant melanoma medicine Nail (anatomy) Humans Hydroxyurea medicine.symptom Longitudinal melanonychia business Nucleic Acid Synthesis Inhibitors medicine.drug |
| Zdroj: | International Journal of Dermatology. 46:13-15 |
| ISSN: | 1365-4632 0011-9059 |
| DOI: | 10.1111/j.1365-4632.2007.03502.x |
| Popis: | A 47-year-old male developed both longitudinal melanonychia and periungual hyperpigmentation 6 months after initiation of hydroxycarbamide (synonym: hydroxyurea) therapy for chronic myeloproliferative disease. Based on the clinical symptoms observed in this patient, the broad differential diagnostic spectrum of hyperpigmentation of the nails is briefly reviewed here. In individuals who undergo hydroxycarbamide treatment, melanonychia might sometimes be seen as side effect and always has to be differentiated from subungual malignant melanoma. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text